PRESS RELEASE published on 04/05/2024 at 00:00, 2 years 1 month ago Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023 Medicure Inc. to present 2023 Year End Financial Results on April 9, 2024, focusing on pharmaceuticals and healthcare products. Conference call details provided Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2023 Year End Financial Results
PRESS RELEASE published on 04/04/2024 at 23:12, 2 years 1 month ago EQS-Adhoc: EVN AG: EVN terminates the structured bidder process for a full sale of WTE and is evaluating further strategic options EVN AG terminates the structured bidder process for full sale of WTE, exploring strategic options to strengthen core business in the energy sector Strategic Options Energy Sector EVN AG Structured Bidder Process WTE
PRESS RELEASE published on 04/04/2024 at 23:00, 2 years 1 month ago RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024 Biophytis announces all resolutions presented at the combined general meeting on April 2, 2024, have been adopted, including financial delegations. Shareholders' mobilization ensured a quorum of nearly 30% Shareholders Biophytis General Meeting Resolutions Approval
PRESS RELEASE published on 04/04/2024 at 23:00, 2 years 1 month ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 2 AVRIL 2024 Biophytis annonce l'adoption de toutes les résolutions lors de son Assemblée Générale Mixte du 2 avril 2024. Les résultats sont disponibles sur leur site. Détails sur les activités et avertissement inclus Biophytis Développement Biotechnologie Assemblée Générale Résultats
REGULATED PRESS RELEASE published on 04/04/2024 at 23:00, 2 years 1 month ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 2 AVRIL 2024 Biophytis annonce l'approbation de toutes les résolutions présentées lors de son Assemblée Générale Mixte. Les détails des votes sont disponibles en ligne. En savoir plus sur BIOPHYTIS et ses candidats-médicaments Biophytis Développement Assemblée Générale Resolutions Candidats-médicaments
REGULATED PRESS RELEASE published on 04/04/2024 at 23:00, 2 years 1 month ago RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024 Biophytis announces approval of all resolutions at the Combined General Meeting held on April 2, 2024, with significant shareholder turnout. The Company specializes in therapeutics for age-related diseases Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
PRESS RELEASE published on 04/04/2024 at 22:05, 2 years 1 month ago Mawson's Subsidiary SXG Announces A$10.23 Million Fully Underwritten Rights Issue Mawson Gold Limited announces fully underwritten pro-rata entitlement offer by subsidiary Southern Cross Gold Ltd. to raise A$10.23 million. Details on Rights Issue at www.southerncrossgold.com.au Gold Exploration Mawson Gold Limited Southern Cross Gold Ltd Rights Issue Underwritten Offer
PRESS RELEASE published on 04/04/2024 at 22:00, 2 years 1 month ago Silver X Mining Closes First Tranche of Non-Brokered Private Placement Silver X Mining Corp. announces closing of first tranche of non-brokered private placement offering, raising $1,108,116 for exploration in Peru. Insiders to participate in second tranche Private Placement Offering Silver X Mining Corp. Insider Participation Peru Exploration Tranche Closing
PRESS RELEASE published on 04/04/2024 at 22:00, 2 years 1 month ago RS&H EVP, Construction Management Leader Doug Geiger Set to Retire in October; Kirk Fauri Named as Successor RS&H Executive Vice President Doug Geiger, PE, retires after 40 years, Kirk Fauri, PE, appointed as new Construction Management National Operations Leader Construction Management Leadership RS&H Doug Geiger Kirk Fauri
PRESS RELEASE published on 04/04/2024 at 21:00, 2 years 1 month ago Black Box Intelligence Appoints Mark Dillon as Chief Executive Officer Black Box Intelligence announces Mark Dillon as new CEO and Joe Henson as Chief Product and Technology Officer. Dillon brings 25 years of tech industry experience Restaurant Industry Chief Product And Technology Officer Black Box Intelligence Mark Dillon Joe Henson
Published on 05/09/2026 at 01:30, 8 hours 7 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 9 hours 37 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 12 hours 58 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 14 hours 24 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 14 hours 34 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 14 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 14 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 14 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 14 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 14 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
